Navigation Links
New research shows emotional impact of low sexual desire and associated distress

Ridgefield, CT, February 18, 2010 New findings from a European study show that women with low sexual desire and associated distress experience personal and emotional distress related to the sexual issue. The findings, presented today at the International Society for the Study of Women's Sexual Health (ISSWSH) 2010 Annual Meeting in St. Petersburg, Fla., are based on a survey of 5,098 women with low sexual desire and associated distress. In the study (DESIRE), many women reported experiencing negative emotions, such as dissatisfaction with their sex life, guilt about sexual difficulties and distress about their sex life, frequently or always during the previous three months.

The DESIRE (Desire and its Effects on female Sexuality Including Relationships) study identified 7,542 women with low sexual desire and associated distress. Among these women, 5,098 participated and were surveyed on a wide range of attitudes and behaviors relating to their experience of low sexual desire. The reports of their frequency and level of sexual desire over the last 12 months were significantly correlated with reports of their level of distress about their low sexual desire and with each of these negative emotional responses.

The DESIRE study methodology consisted of 65,129 women, ages 18-88 years, from France, Germany, Italy, Spain and the UK, participating in a demographically representative research panel. These women completed an initial screening comprised of the first four questions of the Decreased Sexual Desire Screener (DSDS). The DSDS is a five-question diagnostic tool that assists non-expert clinicians in the clinical diagnosis of generalized, acquired Hypoactive Sexual Desire Disorder (HSDD), with more than 85 percent accuracy. In total, 7,542 women answered "yes" to all four questions and did not attribute their desire problem to partner sexual issues or physical trauma and 5,098 women further chose to participate in the in-depth survey.

About the HSDD Patient Registry

To understand the natural course of HSDD in women, the New England Research Institutes in Watertown, Mass., is conducting the first-ever registry in female sexual health. The HSDD Registry for Women is a prospective, multicenter, observational study, which will provide data on the natural history and long-term consequences of HSDD.

"The HSDD Registry for Women is the first sexual medicine registry of its kind to investigate the history and clinical course of generalized, acquired Hypoactive Sexual Desire Disorder in women," said Ray Rosen, Ph.D., Chief Scientist of the New England Research Institutes. "With its in-depth analysis of medical co-morbidities, lifestyle factors and long-term outcomes, we expect the HSDD Registry to address a number of knowledge gaps surrounding HSDD in women."

Nearly one in 10 women report low sexual desire with associated distress, which may be HSDD, an often under-diagnosed condition that is defined as a decrease or lack of sexual desire that causes distress for the patient, may put a strain on relationships with partners, and is not due to the effects of a substance, including medications, or another medical condition.

"Many of the women I see with HSDD experience a high level of guilt and feelings of confusion," said Sheryl Kingsberg, Ph.D., President of ISSWSH, Chief of Behavioral Medicine at University Hospitals Case Medical Center, and professor in reproductive biology at Case Western Reserve University in Cleveland. "They also complain about the distance they feel between themselves and their partner. The emotional impact of HSDD is significant, so I am excited by the growing body of research being presented this year as it provides an in-depth look at this under-recognized but distressing condition."

The study and patient registry are supported by unrestricted grants through Boehringer Ingelheim Pharmaceuticals, Inc.

About the DSDS

The DSDS diagnostic tool consists of five Yes or No questions:

  • In the past, was your level of sexual desire/interest good and satisfying to you?
  • Has there been a decrease in your level of sexual desire/interest?
  • Are you bothered by your decreased level of sexual desire/interest?
  • Would you like your level of sexual desire/interest to increase?

In a fifth Yes or No question, women are asked to note any factors from the following list they feel may be contributing to a loss of sexual desire or interest.

  • Medications, drugs or alcohol you are currently taking
  • Pregnancy, recent childbirth, menopausal symptoms
  • Other sexual issues you may be having (pain, decreased arousal or orgasm)
  • Your partner's sexual problems
  • Dissatisfaction with your relationship or partner
  • Stress or fatigue

If a woman answers "Yes" to questions one through four, and "No" to all of the factors in question five, then she may meet the criteria for the diagnosis of generalized, acquired HSDD. However, following the completion of the DSDS, a clinical assessment and review with the clinician is required to confirm the diagnosis of generalized, acquired HSDD.


Contact: Lara Crissey
Ogilvy Public Relations

Related medicine news :

1. Trade Privacy LLC: Research Concludes Apple Inc. Has Blocked Their Import Records from Public Access
2. Bersin & Associates Unveils Agenda for Research Conference, IMPACT 2010: The Business of Talent(R)
3. Researchers chart genomic map spanning over 2 dozen cancers
4. Dominos Pizza(R) Raises Record Amount for St. Jude Childrens Research Hospital
5. Attorney Joe Belluck Hails Department Of Defense For Increased Funding Of Mesothelioma Research
6. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
7. Research validates surgery alone offers reasonable overall survival for stage I SCLC
8. Clemson researchers develop hands-free texting application
9. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
10. Research finds hazards from secondhand smoke in bars and restaurants
11. UQ research shows canecutters disease on the rise among travelers
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: